- Home
- INDV vs OCTV Comparison
INDV vs OCTV Comparison
Compare INDV & OCTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$40.26
N/A
Current Price
$17.45
Company Overview
Basic Information| Metric | INDV | OCTV |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.8B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | INDV | OCTV |
|---|---|---|
| Price | $40.26 | $17.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 844.7K |
| Earning Date | 06-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | ★ $1,239,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $58.01 | ★ N/A |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $17.10 | $15.41 |
| 52 Week High | $42.81 | $18.38 |
Technical Indicators
Market Signals| Indicator | INDV | OCTV |
|---|---|---|
| Relative Strength Index (RSI) | 52.52 | 61.93 |
| Support Level | $38.47 | $16.56 |
| Resistance Level | $41.42 | $18.38 |
| Average True Range (ATR) | 1.24 | 0.47 |
| MACD | -0.16 | -0.01 |
| Stochastic Oscillator | 51.62 | 98.53 |
Price Performance
Historical Comparison INDV
OCTV
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).